Global Endometriosis Drugs Market Research Report 2022

Global Endometriosis Drugs Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Hormonal Therapy
1.2.3 Add-back Medication
1.2.4 Progestogens
1.2.5 Chinese Herbs
1.3 Market by Application
1.3.1 Global Endometriosis Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endometriosis Drugs Market Perspective (2017-2028)
2.2 Endometriosis Drugs Growth Trends by Region
2.2.1 Endometriosis Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Endometriosis Drugs Historic Market Size by Region (2017-2022)
2.2.3 Endometriosis Drugs Forecasted Market Size by Region (2023-2028)
2.3 Endometriosis Drugs Market Dynamics
2.3.1 Endometriosis Drugs Industry Trends
2.3.2 Endometriosis Drugs Market Drivers
2.3.3 Endometriosis Drugs Market Challenges
2.3.4 Endometriosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Drugs Players by Revenue
3.1.1 Global Top Endometriosis Drugs Players by Revenue (2017-2022)
3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Drugs Revenue
3.4 Global Endometriosis Drugs Market Concentration Ratio
3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2021
3.5 Endometriosis Drugs Key Players Head office and Area Served
3.6 Key Players Endometriosis Drugs Product Solution and Service
3.7 Date of Enter into Endometriosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Drugs Breakdown Data by Type
4.1 Global Endometriosis Drugs Historic Market Size by Type (2017-2022)
4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2023-2028)
5 Endometriosis Drugs Breakdown Data by Application
5.1 Global Endometriosis Drugs Historic Market Size by Application (2017-2022)
5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Endometriosis Drugs Market Size (2017-2028)
6.2 North America Endometriosis Drugs Market Size by Country (2017-2022)
6.3 North America Endometriosis Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Endometriosis Drugs Market Size (2017-2028)
7.2 Europe Endometriosis Drugs Market Size by Country (2017-2022)
7.3 Europe Endometriosis Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Drugs Market Size (2017-2028)
8.2 Asia-Pacific Endometriosis Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Endometriosis Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Endometriosis Drugs Market Size (2017-2028)
9.2 Latin America Endometriosis Drugs Market Size by Country (2017-2022)
9.3 Latin America Endometriosis Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Drugs Market Size (2017-2028)
10.2 Middle East & Africa Endometriosis Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Endometriosis Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Endometriosis Drugs Introduction
11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2017-2022)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Endometriosis Drugs Introduction
11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2017-2022)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Endometriosis Drugs Introduction
11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 Debiopharm Group
11.4.1 Debiopharm Group Company Detail
11.4.2 Debiopharm Group Business Overview
11.4.3 Debiopharm Group Endometriosis Drugs Introduction
11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2017-2022)
11.4.5 Debiopharm Group Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec Endometriosis Drugs Introduction
11.5.4 Evotec Revenue in Endometriosis Drugs Business (2017-2022)
11.5.5 Evotec Recent Development
11.6 Kissei Pharmaceutical
11.6.1 Kissei Pharmaceutical Company Detail
11.6.2 Kissei Pharmaceutical Business Overview
11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2017-2022)
11.6.5 Kissei Pharmaceutical Recent Development
11.7 Neurocrine Biosciences
11.7.1 Neurocrine Biosciences Company Detail
11.7.2 Neurocrine Biosciences Business Overview
11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2017-2022)
11.7.5 Neurocrine Biosciences Recent Development
11.8 ObsEva
11.8.1 ObsEva Company Detail
11.8.2 ObsEva Business Overview
11.8.3 ObsEva Endometriosis Drugs Introduction
11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2017-2022)
11.8.5 ObsEva Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Endometriosis Drugs Introduction
11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2017-2022)
11.9.5 Pfizer Recent Development
11.10 Repros Therapeutics
11.10.1 Repros Therapeutics Company Detail
11.10.2 Repros Therapeutics Business Overview
11.10.3 Repros Therapeutics Endometriosis Drugs Introduction
11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2017-2022)
11.10.5 Repros Therapeutics Recent Development
11.11 Roivant Sciences
11.11.1 Roivant Sciences Company Detail
11.11.2 Roivant Sciences Business Overview
11.11.3 Roivant Sciences Endometriosis Drugs Introduction
11.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2017-2022)
11.11.5 Roivant Sciences Recent Development
11.12 Takeda Pharmaceutical Company
11.12.1 Takeda Pharmaceutical Company Company Detail
11.12.2 Takeda Pharmaceutical Company Business Overview
11.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction
11.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2017-2022)
11.12.5 Takeda Pharmaceutical Company Recent Development
11.13 ValiRx
11.13.1 ValiRx Company Detail
11.13.2 ValiRx Business Overview
11.13.3 ValiRx Endometriosis Drugs Introduction
11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2017-2022)
11.13.5 ValiRx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Add-back Medication
Table 4. Key Players of Progestogens
Table 5. Key Players of Chinese Herbs
Table 6. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Endometriosis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Endometriosis Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Endometriosis Drugs Market Share by Region (2017-2022)
Table 10. Global Endometriosis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Endometriosis Drugs Market Share by Region (2023-2028)
Table 12. Endometriosis Drugs Market Trends
Table 13. Endometriosis Drugs Market Drivers
Table 14. Endometriosis Drugs Market Challenges
Table 15. Endometriosis Drugs Market Restraints
Table 16. Global Endometriosis Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Endometriosis Drugs Market Share by Players (2017-2022)
Table 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2021)
Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometriosis Drugs Product Solution and Service
Table 23. Date of Enter into Endometriosis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Endometriosis Drugs Revenue Market Share by Application (2017-2022)
Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Endometriosis Drugs Revenue Market Share by Application (2023-2028)
Table 33. North America Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Endometriosis Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Endometriosis Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. AbbVie Company Detail
Table 44. AbbVie Business Overview
Table 45. AbbVie Endometriosis Drugs Product
Table 46. AbbVie Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 47. AbbVie Recent Development
Table 48. Astellas Pharma Company Detail
Table 49. Astellas Pharma Business Overview
Table 50. Astellas Pharma Endometriosis Drugs Product
Table 51. Astellas Pharma Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 52. Astellas Pharma Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Endometriosis Drugs Product
Table 56. AstraZeneca Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Debiopharm Group Company Detail
Table 59. Debiopharm Group Business Overview
Table 60. Debiopharm Group Endometriosis Drugs Product
Table 61. Debiopharm Group Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 62. Debiopharm Group Recent Development
Table 63. Evotec Company Detail
Table 64. Evotec Business Overview
Table 65. Evotec Endometriosis Drugs Product
Table 66. Evotec Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 67. Evotec Recent Development
Table 68. Kissei Pharmaceutical Company Detail
Table 69. Kissei Pharmaceutical Business Overview
Table 70. Kissei Pharmaceutical Endometriosis Drugs Product
Table 71. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 72. Kissei Pharmaceutical Recent Development
Table 73. Neurocrine Biosciences Company Detail
Table 74. Neurocrine Biosciences Business Overview
Table 75. Neurocrine Biosciences Endometriosis Drugs Product
Table 76. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 77. Neurocrine Biosciences Recent Development
Table 78. ObsEva Company Detail
Table 79. ObsEva Business Overview
Table 80. ObsEva Endometriosis Drugs Product
Table 81. ObsEva Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 82. ObsEva Recent Development
Table 83. Pfizer Company Detail
Table 84. Pfizer Business Overview
Table 85. Pfizer Endometriosis Drugs Product
Table 86. Pfizer Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Repros Therapeutics Company Detail
Table 89. Repros Therapeutics Business Overview
Table 90. Repros Therapeutics Endometriosis Drugs Product
Table 91. Repros Therapeutics Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 92. Repros Therapeutics Recent Development
Table 93. Roivant Sciences Company Detail
Table 94. Roivant Sciences Business Overview
Table 95. Roivant Sciences Endometriosis DrugsProduct
Table 96. Roivant Sciences Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 97. Roivant Sciences Recent Development
Table 98. Takeda Pharmaceutical Company Company Detail
Table 99. Takeda Pharmaceutical Company Business Overview
Table 100. Takeda Pharmaceutical Company Endometriosis DrugsProduct
Table 101. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 102. Takeda Pharmaceutical Company Recent Development
Table 103. ValiRx Company Detail
Table 104. ValiRx Business Overview
Table 105. ValiRx Endometriosis DrugsProduct
Table 106. ValiRx Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
Table 107. ValiRx Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Drugs Market Share by Type: 2021 VS 2028
Figure 2. Hormonal Therapy Features
Figure 3. Add-back Medication Features
Figure 4. Progestogens Features
Figure 5. Chinese Herbs Features
Figure 6. Global Endometriosis Drugs Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Endometriosis Drugs Report Years Considered
Figure 11. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Endometriosis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Endometriosis Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Endometriosis Drugs Market Share by Players in 2021
Figure 15. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2021
Figure 17. North America Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Endometriosis Drugs Market Share by Country (2017-2028)
Figure 19. United States Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Endometriosis Drugs Market Share by Country (2017-2028)
Figure 23. Germany Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Endometriosis Drugs Market Share by Region (2017-2028)
Figure 31. China Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Endometriosis Drugs Market Share by Country (2017-2028)
Figure 39. Mexico Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Endometriosis Drugs Market Share by Country (2017-2028)
Figure 43. Turkey Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 46. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 47. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 48. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 49. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 50. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 51. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 52. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 53. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 54. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 55. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 56. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 57. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs